Pfizer Public Policy

Through our public policy efforts at Pfizer, we are able to connect to the many groups who have an interest in our company and our pharmaceutical products: patients, physicians, insurers, employers, shareholders, employees and policy makers. Engaging in public policy debates is part of our responsibility because effective policies help create an environment in which innovation is encouraged, new medicines are brought to market, and the good health of patients remains an enduring priority.

We invite you to browse through the Public Policy section of this web site to learn about our positions on important health care issues.

Pfizer is committed to engaging in public policy debate to continue to improve the efforts of the pharmaceutical industry and to increase access to prescription medicine for people around the world.

• Comparative Effectiveness Research
• Essential Benefits
• Government Program Rebates and Discounts
• Health Care Reform
• Health Insurance Exchanges
• Medicaid Expansion
• Medicare Part D Coverage Gap Discount Program